Procalcitonin serum levels in children undergoing chronic haemodialysis

Pediatric Nephrology

Volumn 22, Issue 3, 2007, Pages 430-435

  Lorton, Fleur ^a   Veinberg, Frédérique ^a   Ielsch, Dominique ^a   Deschênes, Georges ^a   Bensman, Albert ^a   Ulinski, Tim ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Dialysability; End stage renal disease; Haemodialysis; Infection; Micro inflammation; Procalcitonin

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; LOW MOLECULAR WEIGHT HEPARIN; PROCALCITONIN;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY CLEARANCE; KIDNEY FAILURE; LONG TERM CARE; MALE; PRIORITY JOURNAL; UREMIA;

ADOLESCENT; BACTERIAL INFECTIONS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROTEIN PRECURSORS; RENAL DIALYSIS;

EID: 34248677852     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0304-2     Document Type: Article

References (29)

1. Khan IH, Catto GR (1993) Long-term complications of dialysis: Infection. Kidney Int Suppl 41:S143-S148
2. Hoenich NA, Johnston SR, Woffindin C, Kerr DN (1984) Haemodialysis leucopenia: The role of membrane type and re-use. Contrib Nephrol 37:120-128
3. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM (1996) Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 16:158-162
4. Owen WF, Lowrie EG (1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636
5. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S (1991) Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 57:283-287
6. Conti G, Amore A, Chiesa M, Mancuso D, Cirina P, Mengozzi G, Santoro A, Coppo R (2005) Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol 18: 282-288
7. Dahaba AA, Rehak PH, List WF (2003) Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 29:579-583
8. Sitter T, Schmidt M, Schneider S, Schiffl H (2002) Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 15:297-301
9. Herget-Rosenthal S, Marggraf G, Pietruck F, Husing J, Strupat M, Philipp T, Kribben A (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16:975-979
10. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396-404
11. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jager L, Reinhart K (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134:49-55
12. Balog A, Ocsovszki I, Mandi Y (2002) Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunol Lett 84:199-203
13. Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:888-889
14. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608
15. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001-1006
16. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4:620-630
17. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin - a new indicator of the systemic response to severe infections. Infection 25:329-334
18. Balc IC, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B (2003) Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 7:85-90
19. Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, Hart CA (2002) Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 86:282-285
20. Hoffmann U, Fischereder M, Marx M, Schweda F, Lang B, Straub RH, Kramer BK (2003) Induction of cytokines and adhesion molecules in stable hemodialysis patients: Is there an effect of membrane material? Am J Nephrol 23:442-447
21. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N (1990) Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 38:1089-1094
22. Lonnemann G, Haubitz M, Schindler R (1990) Hemodialysis-associated induction of cytokines. Blood Purif 8:214-222
23. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA (2002) Inflammatory signals associated with hemodialysis. Kidney Int 62:1408-1416
24. Haeffner-Cavaillon N, Jahns G, Poignet JL, Kazatchkine MD (1993) Induction of interleukin-1 during hemodialysis. Kidney Int Suppl 39:S139-143
25. Haubitz M, Schulze M, Koch KM (1990) Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 5:500-503
26. Visvardis G, Griveas I, Fleva A, Giannakou A, Papadopoulou D, Mitsopoulos E, Kyriklidou P, Manou E, Ginikopoulou E, Meimaridou D, Pavlitou K, Sakellariou G (2005) Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Ren Fail 27:429-434
27. Level C, Chauveau P, Delmas Y, Lasseur C, Pelle G, Peuchant E, Montaudon D, Combe C (2001) Procalcitonin: A new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 16:980-986
28. Horl WH (2002) Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 13 Suppl 1:S62-71
29. Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H (2000) Procalcitonin in patients undergoing chronic hemodialysis. Nephron 84:187-188